BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee’s dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was incorrporated in 1990 and is based in Stockholm, Sweden.
Metrics to compare | BIOGb | Peers Peers - average of corresponding metrics from companies closely matching BIOGb: PROB, VITR, NOVN, CRNOSb_old, EGTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBIOGbPeersSector |
---|---|---|---|---|
P/E Ratio | 32.7x | −1.4x | −0.6x | |
PEG Ratio | −1.42 | −0.03 | 0.00 | |
Price/Book | 6.8x | 2.2x | 2.6x | |
Price / LTM Sales | 8.1x | 8.1x | 3.2x | |
Upside (Analyst Target) | 37.9% | 85.0% | 40.6% | |
Fair Value Upside | Unlock | 22.6% | 7.1% | Unlock |